Kinugasa, Hideaki <br/><br/>
Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection.  [electronic resource] 

 -  Antiviral therapy  2016 
 - 37-44 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP2976  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amino Acid Substitution<br/>Antiviral Agents--pharmacology<br/>Biomarkers<br/>Carbamates<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--pharmacology<br/>Isoquinolines--pharmacology<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Pyrrolidines<br/>Retreatment<br/>Sulfonamides--pharmacology<br/>Time Factors<br/>Treatment Failure<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Viral Load<br/>Viral Nonstructural Proteins--genetics